Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1030 of 5804
-
New drug combo aims to tame rare kidney diseases
Disease control Recruiting nowThis is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults with complement-mediated kidney diseases. The study will enroll Chinese adults with IgA nephropathy, complement 3 glomerulopathy (C3G) and immune complex membra…
Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kids with rare seizure disorder: ION337 trial launches
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).
Phase: PHASE1, PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug rebecsinib enters human testing for tough blood cancers
Disease control Recruiting nowThe purpose of this study is to test the safest and most effective dose of a new investigational drug, rebecsinib. Participants in this study will have either Secondary Acute Myeloid Leukemia (sAML) that has either returned (relapsed) or not responded to treatment (refractory) or…
Phase: PHASE1 • Sponsor: Aspera Biomedicines, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
Disease control Not yet recruitingThe Azithromycin to Modify Bronchiectasis Exacerbation Risk (AMBER) trial is a prospective, randomized, double-blind, placebo-controlled, parallel-group clinical trial in adults with clinically and radiologically confirmed non-cystic fibrosis bronchiectasis (NCFB). The trial eva…
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a blood spin help you get pregnant? new trial tests PRP in IUI
Disease control Not yet recruitingThe investigators hypothesize that infertility patients undergoing IUI who receive female autologous platelet-rich plasma (PRP) co-incubation with husband's sperm would have higher clinical pregnancy rate. Primary outcome: To compare the incidence of clinical pregnancy outcome …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug could slow kidney disease in 182 patients
Disease control Not yet recruitingThe purpose of the study was to evaluate the efficacy and safety of HS-10390 in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) ≥ 30 and \<90 mL/min/1.73 m\^2, and urinary albumin to creatinine ratio (UACR) ≥ 150 mg/g and \< 3000 mg…
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a common supplement fight chemo brain? new trial aims to find out
Symptom relief Recruiting nowThis is a phase I, dose-escalation and phase II dose-expansion clinical trial determining the maximum tolerated dose (MTD) and safety and tolerability of adding N-Acetyl-Cysteine (NAC) to ovarian cancer patients who are receiving a platinum-based therapy (PBT). This study will in…
Phase: PHASE1, PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
AI eye on the colon: new trial tests smart detection for sneaky polyps
Diagnosis Recruiting nowThe aim of this study is to is to evaluate if a real-time Computer Aided Detection (CADe) system can help improve the detection of SSL(sessile serrated lesions) versus a conventional colonoscopy (CC) using white light examination(WLE).
Phase: NA • Sponsor: National Healthcare Group, Singapore • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThe main purpose of the study is to evaluate the safety, tolerability and recommended dose of PM54 in combination with pembrolizumab. To assess the antitumor activity of PM54 in combination with pembrolizumab in terms of clinical benefit rate (CBR) and objective response rate (OR…
Phase: PHASE1, PHASE2 • Sponsor: PharmaMar • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New injection could unpinch nerves in diabetic legs
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a single session of ultrasound-guided nerve hydrodissection can relieve symptoms of diabetic lower limb entrapment neuropathy, a condition caused by compressed nerves in the leg that leads to numbness, pain, or muscle weakness in peo…
Phase: NA • Sponsor: Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Lung cancer surgery showdown: less invasive sampling may match full dissection
Disease control Not yet recruitingThe SCIENCE trial is a multicenter, open-label, randomized, parallel, noninferiority investigator-initiated trial (IIT). This study aims to evaluate the prognostic differences between selective mediastinal lymph node sampling and systematic mediastinal lymph node dissection in pa…
Phase: PHASE3 • Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Ultrasound may spare breast cancer patients unnecessary surgery
Diagnosis Not yet recruitingThis study aims to evaluate whether longitudinal multimodal ultrasound can accurately predict axillary pathological response in breast cancer patients who receive neoadjuvant chemotherapy. In this study, patients with biopsy-proven metastatic axillary lymph nodes will have a meta…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Could a simple steroid injection keep your airway open longer?
Disease control Recruiting nowThis study will examine the ability of steroid injections into the site of stenosis following surgical dilation to delay the need for repeated surgical dilations.
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for kids with tough leukemia: experimental drug enters human testing
Disease control Recruiting nowAcute myeloid leukemia (AML) is an aggressive blood cancer, withwith few options for participants who relapse after treatment or who don't respond to treatment. This study will assess the adverse events and how pivekimab sunirine moves through the body in pediatric participants w…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New study to test best heart rhythm fix for seniors
Disease control Not yet recruitingACE-AF is a multicenter randomized study in people aged 78 years and older with symptomatic atrial fibrillation (AF). AF is a common heart rhythm disorder in older adults and can cause reduced quality of life and lead to serious complications such as stroke and heart failure. Th…
Phase: NA • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a simple arm cuff replace bloodletting for high altitude disease?
Disease control Not yet recruitingThis study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The participants are adult patients with high-altitude polycythemia who have been long-term residents (for \>6 months) in regions at an altitude of ≥2500 meters. Participants are…
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New strategy training aims to outsmart Parkinson's brain fog
Symptom relief Recruiting nowMild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunat…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Brain cell injection could tame Drug-Resistant epilepsy
Disease control Not yet recruitingThis is a phase I study (Protocol: UX-GIP001-102) investigating UX-GIP001 Injection, a novel cell therapy product consisting of human GABAergic interneuron progenitor cells (GIP), for treating adult patients with drug-resistant unilateral medial temporal lobe epilepsy (MTLE). The…
Phase: PHASE1 • Sponsor: Shanghai UniXell Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tests Clot-Busting procedure for severe leg clots
Disease control Recruiting now* Iliofemoral DVTs (IF DVTs) are vascular disorders associated with high morbidity and mortality, which can be complicated by long-term post-thrombotic syndrome (PTS). * Pharmaco mechanical thrombolysis (PMT) is an innovative endovascular technique involving in situ fibrinolysis …
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy for bile duct cancer enters safety trial
Disease control Recruiting nowThe goal of this clinical trial is to provide evidence for the general tolerability of radiofrequency ablation (bRFA) in patients with unresectable bile duct cancer undergoing systemic palliative treatment consisting of systemic anti-tumor therapy with or without immune-checkpoin…
Phase: PHASE2 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC